• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大血管闭塞所致急性缺血性卒中血管内血栓切除术后影像学和症状性出血转化的预测因素

Predictors of Radiographic and Symptomatic Hemorrhagic Conversion Following Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion.

作者信息

Javed Kainaat, Boyke Andre, Naidu Ishan, Ryvlin Jessica, Fluss Rose, Fortunel Adisson N, Dardick Joseph, Kadaba Devikarani, Altschul David J, Haranhalli Neil

机构信息

Neurological Surgery, Montefiore Medical Center, New York, USA.

Neurological Surgery, John Hopkins University, Baltimore, USA.

出版信息

Cureus. 2022 Apr 24;14(4):e24449. doi: 10.7759/cureus.24449. eCollection 2022 Apr.

DOI:10.7759/cureus.24449
PMID:35637796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9129917/
Abstract

Background Endovascular therapy is known to achieve a high rate of recanalization in patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO) and is currently the standard of care. Hemorrhagic conversion is a severe complication that may occur following AIS in patients undergoing endovascular thrombectomy (EVT). There is a scarcity of data on the risk factors related to HV in post-EVT patients, especially those who develop symptomatic hemorrhagic conversion. The main objective of our study is to identify independent predictors of radiographic and symptomatic hemorrhagic conversion in our diverse patient population with multiple baseline comorbidities that presented with AIS and were treated with EVT as per the most updated guidelines and practices. Methodology This is a retrospective chart review in which we enrolled adult patients treated with EVT for AIS at a comprehensive stroke center in the Bronx, NY, over a four-year period. Bivariate analyses followed by multiple logistic regression modeling were performed to determine the independent predictors of all and symptomatic hemorrhagic conversion. Results A total of 326 patients who underwent EVT for AIS were enrolled. Of these, 74 (22.7%) had an HC, while 252 (77.3%) did not. In total, 25 out of the 74 (33.7%) patients were symptomatic. In the logistic regression model, a history of prior ischemic stroke (odds ratio (OR) = 2.197; 95% confidence interval (CI) = 1.062-4.545; p-value = 0.034), Alberta Stroke Program Early CT Score (ASPECTS) of <6 (OR = 2.207; 95% CI = 1.477-7.194; p-value = 0.019), and Thrombolysis in Cerebral Infarction (TICI) 2B-3 recanalization (OR = 2.551; 95% CI = 1.998-6.520; p-value=0.045) were found to be independent predictors of all types of hemorrhagic conversion. The only independent predictor of symptomatic hemorrhagic conversion on multiple logistic regression modeling was an elevated international normalized ratio (INR) (OR = 11.051; 95% CI = 1.866-65.440; p-value = 0.008). Conclusions History of prior ischemic stroke, low ASPECTS score, and TICI 2B-3 recanalization are independent predictors of hemorrhagic conversion while an elevated INR is the only independent predictor of symptomatic hemorrhagic conversion in post-thrombectomy patients.

摘要

背景 已知血管内治疗可使因大血管闭塞(LVO)导致的急性缺血性卒中(AIS)患者实现较高的再通率,目前是标准治疗方法。出血性转化是接受血管内血栓切除术(EVT)的AIS患者可能发生的严重并发症。关于EVT术后患者出血性转化相关危险因素的数据稀缺,尤其是那些发生症状性出血性转化的患者。我们研究的主要目的是在我们多样化的患者群体中确定影像学和症状性出血性转化的独立预测因素,这些患者有多种基线合并症,表现为AIS,并按照最新指南和实践接受了EVT治疗。

方法 这是一项回顾性病历审查,我们纳入了纽约布朗克斯区一家综合卒中中心在四年期间接受EVT治疗AIS的成年患者。进行双变量分析,然后进行多因素逻辑回归建模,以确定所有类型和症状性出血性转化的独立预测因素。

结果 共有326例接受AIS的EVT治疗的患者被纳入。其中,74例(22.7%)发生了出血性转化,而252例(77.3%)未发生。在74例患者中,共有25例(33.7%)出现症状。在逻辑回归模型中,既往缺血性卒中史(优势比(OR)=2.197;95%置信区间(CI)=1.062 - 4.545;p值=0.034)、阿尔伯塔卒中项目早期CT评分(ASPECTS)<6(OR = 2.207;95%CI = 1.477 - 7.194;p值=0.019)以及脑梗死溶栓(TICI)2B - 3级再通(OR = 2.551;95%CI = 1.998 - 6.520;p值=0.045)被发现是所有类型出血性转化的独立预测因素。多因素逻辑回归建模中症状性出血性转化的唯一独立预测因素是国际标准化比值(INR)升高(OR = 11.051;95%CI = 1.866 - 65.440;p值=0.008)。

结论 既往缺血性卒中史、低ASPECTS评分和TICI 2B - 3级再通是出血性转化的独立预测因素,而INR升高是血栓切除术后患者症状性出血性转化的唯一独立预测因素。

相似文献

1
Predictors of Radiographic and Symptomatic Hemorrhagic Conversion Following Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion.大血管闭塞所致急性缺血性卒中血管内血栓切除术后影像学和症状性出血转化的预测因素
Cureus. 2022 Apr 24;14(4):e24449. doi: 10.7759/cureus.24449. eCollection 2022 Apr.
2
Severe Cerebral Small Vessel Disease Burden Is Associated With Poor Outcomes After Endovascular Thrombectomy in Acute Ischemic Stroke With Large Vessel Occlusion.在伴有大血管闭塞的急性缺血性卒中患者中,严重脑小血管病负担与血管内血栓切除术后不良预后相关。
Cureus. 2021 Feb 4;13(2):e13122. doi: 10.7759/cureus.13122.
3
External validation of TICI-ASPECTS-glucose score as a predictive model for symptomatic intracranial hemorrhage following mechanical thrombectomy.TICI-ASPECTS 葡萄糖评分对机械取栓后症状性颅内出血的预测价值的外部验证。
J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106796. doi: 10.1016/j.jstrokecerebrovasdis.2022.106796. Epub 2022 Sep 29.
4
Clinical and imaging predictors for hemorrhagic transformation of acute ischemic stroke after endovascular thrombectomy.血管内血栓切除术治疗急性缺血性脑卒中后出血性转化的临床及影像学预测因素。
J Neuroimaging. 2024 May-Jun;34(3):339-347. doi: 10.1111/jon.13191. Epub 2024 Jan 31.
5
Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis.依替巴肽在接受血管内血栓切除术的缺血性中风患者中的应用:一项匹配队列分析。
Front Neurol. 2022 Sep 27;13:939215. doi: 10.3389/fneur.2022.939215. eCollection 2022.
6
Endovascular thrombectomy or bridging therapy in minor ischemic stroke with large vessel occlusion.血管内血栓切除术或桥接治疗小面积缺血性卒中伴大血管闭塞。
Thromb Res. 2022 Nov;219:150-154. doi: 10.1016/j.thromres.2022.09.020. Epub 2022 Sep 25.
7
The comparison of mechanical thrombectomy and symptomatic therapy on early outcome of acute ischemic stroke in patients older than 80 years: A retrospective cohort study.比较 80 岁以上急性缺血性脑卒中患者机械取栓与症状治疗对早期结局的影响:一项回顾性队列研究。
Clin Neurol Neurosurg. 2022 Oct;221:107378. doi: 10.1016/j.clineuro.2022.107378. Epub 2022 Jul 21.
8
Intravenous fibrinolysis plus endovascular thrombectomy versus direct endovascular thrombectomy for anterior circulation acute ischemic stroke: clinical and infarct volume results.静脉溶栓联合血管内血栓切除术与直接血管内血栓切除术治疗前循环急性缺血性卒中:临床及梗死体积结果
BMC Neurol. 2019 May 29;19(1):103. doi: 10.1186/s12883-019-1341-3.
9
Safety and efficacy of remote ischemic conditioning combined with endovascular thrombectomy for acute ischemic stroke due to large vessel occlusion of anterior circulation: A multicenter, randomized, parallel-controlled clinical trial (SERIC-EVT): Study protocol.远程缺血预处理联合血管内取栓治疗前循环大动脉闭塞性急性缺血性脑卒中的安全性和有效性的多中心、随机、平行对照临床试验(SERIC-EVT):研究方案。
Int J Stroke. 2023 Apr;18(4):484-489. doi: 10.1177/17474930221121429. Epub 2022 Sep 12.
10
Comprehensive Meta-Analysis of Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: Prevalence, Factors, and Clinical Outcomes.急性缺血性卒中患者接受血管内血栓切除术时无效再通的综合荟萃分析:发生率、影响因素及临床结局
Life (Basel). 2023 Sep 26;13(10):1965. doi: 10.3390/life13101965.

引用本文的文献

1
Predictors of outcome and symptomatic intracranial hemorrhage in acute basilar artery occlusions: Analysis of the PC-SEARCH thrombectomy registry.急性基底动脉闭塞中结局和症状性颅内出血的预测因素:PC-SEARCH 取栓登记研究分析。
Eur Stroke J. 2024 Sep;9(3):583-591. doi: 10.1177/23969873241234713. Epub 2024 Feb 25.
2
Effect of admission in the stroke care unit versus intensive care unit on in-hospital mortality in patients with acute ischemic stroke.急性缺血性脑卒中患者入住卒中护理单元与重症监护病房对院内死亡率的影响。
BMC Neurol. 2023 Nov 13;23(1):402. doi: 10.1186/s12883-023-03454-6.

本文引用的文献

1
Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy.血管内血栓切除术后急性缺血性卒中出血转化的临床及影像学指标
Stroke. 2022 May;53(5):1674-1681. doi: 10.1161/STROKEAHA.121.035425. Epub 2021 Dec 7.
2
Different Scores Predict the Value of Hemorrhagic Transformation after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.不同评分可预测急性缺血性脑卒中患者静脉溶栓后出血转化的价值。
Evid Based Complement Alternat Med. 2021 Oct 21;2021:2468052. doi: 10.1155/2021/2468052. eCollection 2021.
3
Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.急性缺血性脑卒中患者接受组织型纤溶酶原激活物治疗后的出血性转化。
Cell Mol Neurobiol. 2022 Apr;42(3):621-646. doi: 10.1007/s10571-020-00985-1. Epub 2020 Oct 30.
4
The Role of Hemorrhagic Transformation in Acute Ischemic Stroke Upon Clinical Complications and Outcomes.出血性转化在急性缺血性卒中临床并发症及预后中的作用。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104898. doi: 10.1016/j.jstrokecerebrovasdis.2020.104898. Epub 2020 May 13.
5
Haemorrhagic transformation following ischaemic stroke: A retrospective study.出血性转化与缺血性脑卒中:一项回顾性研究。
Sci Rep. 2020 Mar 24;10(1):5319. doi: 10.1038/s41598-020-62230-5.
6
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
7
Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study.机械取栓术后实质血肿的预测因素:一项多中心研究。
Stroke. 2019 Sep;50(9):2364-2370. doi: 10.1161/STROKEAHA.118.024512. Epub 2019 Jul 22.
8
Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.中国接受重组组织型纤溶酶原激活物静脉溶栓治疗的急性缺血性脑卒中患者发生出血性转化的风险因素:系统评价和荟萃分析。
Stroke Vasc Neurol. 2018 May 26;3(4):203-208. doi: 10.1136/svn-2018-000141. eCollection 2018 Dec.
9
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.缺血性脑卒中血脑屏障损伤的神经炎症机制。
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153. doi: 10.1152/ajpcell.00136.2018. Epub 2018 Oct 31.
10
Hemorrhagic Transformations after Thrombectomy: Risk Factors and Clinical Relevance.血栓切除术后的出血性转化:危险因素及临床意义
Cerebrovasc Dis. 2017;43(5-6):294-304. doi: 10.1159/000460265. Epub 2017 Mar 25.